Ntla stock forecast.

NTLA stock forecast for 2023 – 2027 Last updated: November 23, 2023 NTLA Intellia Therapeutics, Inc. 30.26 D 6.32% (1.80) Are you interested in Intellia …Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceGet The Latest QCOM Stock Analysis, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. ... Being profitable and raising its production forecast are two reasons the Chinese EV maker Li Auto distinctly stands out from its peers Nio and Xpeng. November 13, 2023 | marketbeat ...4 Growth Stocks, 4 Value Stocks to Buy Each stock offers a different opportunity in this uncertain market outlook. Jeff Reeves and Jordan Schultz Nov. 27, 2023Stock Price Forecast. The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +175.23% increase from the last price of 26.16.

NTLA-2001: NTLA-2001 is the first investigational CRISPR-based therapy to be systemically delivered to edit genes inside the human body and has the potential to be the first single-dose treatment for ATTR amyloidosis. ... (ATM) agreement and $14.3 million in proceeds from employee-based stock plans. Collaboration Revenue: ...

Jul 6, 2023 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance About the Intellia Therapeutics, Inc. stock forecast. As of 2023 November 30, Thursday current price of NTLA stock is 30.900$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

Current. -$1.48. 1 Month Ago. -$1.60. 3 Months Ago. -$1.63. Intellia Therapeutics Inc. analyst estimates, including NTLA earnings per share estimates and analyst recommendations. See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The latest Intellia Therapeutics stock prices, stock quotes, news, and NTLA history to help you invest and trade smarter. ... The 61 analysts offering price forecasts for Intellia Therapeutics ... Find the latest Intellia Therapeutics, Inc. NTLA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +137.08% increase from the last price of 30.37. The current consensus among 27 polled investment analysts is to Buy stock in Intellia ...

Discover historical prices for NTLA stock on Yahoo Finance. View daily, weekly or monthly format back to when Intellia Therapeutics, Inc. stock was issued.

The 24 analysts offering 1 year price forecasts for NTLA have a max estimate of — and a min estimate of —. Analyst rating Based on 27 analysts giving stock ratings to NTLA in …

The anecdotal wisdom is that the way to outperform the market this year has been to flock to the Magnificent Seven stocks (AAPL, AMZN, Google, META, MSFT, Latest NewsShares of Intellia Therapeutics, Inc. (NTLA) have gained 23.5% over the past four weeks to close the last trading session at $43.19, but there could still be a solid upside left in the stock if ...4 Growth Stocks, 4 Value Stocks to Buy Each stock offers a different opportunity in this uncertain market outlook. Jeff Reeves and Jordan Schultz Nov. 27, 2023١٤‏/١١‏/٢٠٢٣ ... Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best ...Blair reiterated a Buy rating for NTLA stock.All in all, Wall Street has a Strong Buy consensus rating for NTLA stock, with 15 Buys and three Holds. At $102.11, the average NTLA stock price target ...The average one-year price target for NTLA / Intellia Therapeutics Inc is $84.617. The forecasts range from a low of $38.38 to a high of $164.85. A stock’s price target is the price at which analysts consider it fairly valued with respect to …What are analysts forecasts for Intellia Therapeutics stock? The 61 analysts offering price forecasts for Intellia Therapeutics have a median target of 93.70, with a high estimate of 180.00 and a ...

For their last quarter, Intellia Therapeutics (NTLA) reported earnings of -$1.40 per share, missing the Zacks Consensus Estimate of -$1.32 per share. This reflects a negative earnings surprise of ...The average Editas Medicine stock forecast 2024 represents a 3.79% increase from the last price of $10.5299997329712. For Editas Medicine stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Editas Medicine stock forecast of $10.98, a high forecast of $12.02, and a low forecast of $10.15.Oct 18, 2023 · On today's stock market, NTLA stock skidded 3.8%, reversing from a premarket climb and closing at 27.96. Shares of Regeneron Pharmaceuticals ( REGN ), which is collaborating with Intellia on the ... Find real-time NTLA - Intellia Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of -6.06% and 2.58%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the ...A high-level overview of Intellia Therapeutics, Inc. (NTLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Nov 30, 2023 · Stock Price Forecast. According to 20 stock analysts, the average 12-month stock price forecast for NTLA stock stock is $77.4, which predicts an increase of 149.44%. The lowest target is $39 and the highest is $136. On average, analysts rate NTLA stock stock as a buy.

Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to ...

Blair reiterated a Buy rating for NTLA stock.All in all, Wall Street has a Strong Buy consensus rating for NTLA stock, with 15 Buys and three Holds. At $102.11, the average NTLA stock price target ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...In the same period, the company plans to submit an IND for NTLA-3001, its therapy for alpha-1 antitrypsin deficiency-related lung disease that's presently in early-stage trials.Jun 19, 2023 · Even after rising 30% so far this year, shares of Intellia Therapeutics ( NTLA 4.88%) could easily experience another leg up if there's a bull market in the latter half of 2023. With positive ... 4 Growth Stocks, 4 Value Stocks to Buy Each stock offers a different opportunity in this uncertain market outlook. Jeff Reeves and Jordan Schultz Nov. 27, 2023Alibaba Stock Forecast For Tomorrow, Week, Month. NTLA Stock Forecast 2023, 2024, 2025. Alibaba stock price predictions for March 2024. The forecast for beginning of March 67.45. Maximum value 72.59, while minimum 64.37. Averaged Alibaba stock price for month 68.22. Price at the end 68.48, change for March 1.53%.Nov 23, 2023 · NTLA stock forecast for 2023 – 2027. Last updated: November 23, 2023. NTLA. Intellia Therapeutics, Inc. 30.26 D 6.32% (1.80) Are you interested in Intellia Therapeutics, Inc. stocks prediction?

Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...

According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.

Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...NTLA Stock Forecast For Tomorrow, Week, Month. SRNE Stock Forecast 2023, 2024, 2025. Intellia Therapeutics stock price predictions for March 2024. The forecast for beginning of March 27.91. Maximum value 30.29, while minimum 26.87. Averaged Intellia Therapeutics stock price for month 28.41. Price at the end 28.58, change for March 2.40%.Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Intellia Therapeutics, Inc. (NTLA) : Free Stock Analysis Report. To read this article on Zacks.com click ...Three Fool.com contributors have identified beaten-down stocks of relatively small companies that could soar this year. Here's why they picked CRISPR Therapeutics ( CRSP 4.39%), Exelixis ( EXEL 0. ...Aug 3, 2023 · Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $1.40 per share versus the Zacks Consensus Estimate of a loss of $1.32. This compares to loss of $1.33 per share a year ago. Intellia was founded in 2014 and went public in 2016, raising net proceeds of $112.1 million at $18 per share. The stock currently trades around $36.00 a share, translating to a market cap of $3. ...The global RPA market reached $2.3 billion in 2022, and Grand View Research forecasts that it will grow at an annualized rate of 39.3% from 2023 through 2030. If you want to follow Wood and buy ...١٥‏/٠٦‏/٢٠٢٣ ... Warning flags for any stock MBOT's arbitrary price targets ... Is NTLA the Best Gene Editing Stock? Nanalyze New 654 views · 43:57. Go ...Stock Price Forecast The 17 analysts offering 12-month price forecasts for Sanofi SA have a median target of 55.54, with a high estimate of 67.44 and a low estimate of 43.76.Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

Apr 18, 2023 · That revenue goes along with positive earnings per share of $12.83 in 2022. And the forecast is that Vertex will grow earnings in 2023. ... Analysts are bullish on NTLA stock. It currently has a ... Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business.Jun 28, 2021 · Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics. ... And for 2028, analysts forecast the sector to bring in revenue ... Instagram:https://instagram. ishares msci japan etfgilead science stockdown payment on commercial propertysgold stock Intellia Therapeutics has recently been granted FDA clearance to include the United States in the global Phase 2 portion of its Phase 1/2 study for NTLA-2002. This is a significant milestone for ... 13 f filingbidenomics is working Intellia Therapeutics (NTLA) Receives a Buy from Stifel Nicolaus. Stifel nicolaus analyst dae gon ha maintained a buy rating on intellia therapeutics (ntla) on november 10. Gon ha covers the healthcare sector and has an average return of -5.4% and a 31.07% success rate on recommended stocks. The company's shares closed last friday at $24.13.Stocks making the biggest moves midday: Tesla, Disney, Alibaba, Ulta Beauty and more. Published Fri, Dec 1 202312:20 PM EST. Samantha Subin … moomoo commission fee (See NTLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy , a newly launched tool that unites all of TipRanks’ equity insights.The stock is trading at $62.69 and its $108.64 indicates a 73% one-year gain lying ahead for NTLA. (See NTLA stock forecast on TipRanks)To find good ideas for stocks trading at attractive ...Intellia has declined in the double digits over the past year. Superstar investor Cathie Wood is increasing her bet on a cutting-edge technology that could transform the treatment of many diseases ...